Stealth Virus Symptoms
Viruses are infection-causing agents that multiply within cells. While this is the general definition for any virus, in the case of stealth viruses, the ability of the cell to recognize the antigen, or the healing agent, is lost. This results in progressive degeneration of the cells. As of 2009, the Center for Complex Infectioius Diseases (CCID) reports that some doctors believe stealth virus may be present in the cells of all potentially self-destroying diseases.
Effects of Stealth Virus
Stealth viruses predominantly, but not always, affect the brain. They cause a wide array of progressively degenerative neurological, allergic, neoplastic, auto immune and psychiatric illnesses. Emerging Worlds.com reports that doctors believe stealth viruses may also be involved in the growth of cancer cells.
Stealth cells are primarily identified in a vast range of diseases that are characterized by the degeneration of brain cells. These diseases include multiple sclerosis, autism, Alzheimer’s disease, schizophrenia, depression and attention deficit disorder.
Given the wide gamut of diseases stealth viruses may cause, it is difficult to identify a single set of symptoms associated with the viruses. Identifying or diagnosing stealth cells is challenging not only because they are atypical, but also because they can escape detection by standard medical tests such as blood tests. Moreover, stealth viruses are of totally unrelated origins, and can mutate unpredictably.
Stealth virus symptoms, depending on the strain of the virus, can include depression, chronic fatigue, memory loss, brain dysfunction, mysterious seizures, developmental delays and cognitive difficulty. These symptoms can be anywhere from very mild to moderate to very severe.
Detailed neurological tests must be conducted to zero in on the virus, due to its unpredictable nature. Other diagnosis methods include EEG, SPECT scans and neuro-cognitive assessments.
Since stealth viruses are extremely heterogeneous and disparate by their nature, a precisely defined set of treatment options are not available. Any treatment is usually aimed at first inhibiting the growth of these viruses, and then stimulating normal cell metabolism.
Both these treatments must be specific to the strain of the virus, and often have to supplement treatments that are administered to address the symptoms of the disease. The CCID suggests that certain chemokines may be effective at treating some types of cell viruses, however, more research is required before this is accepted as a standard line of treatment for stealth viruses.